DEA bans “Pink”
DEA bans “Pink” This week, the US Drug enforcement Administration (DEA) classified “Pink” a schedule I drug. The synthetic opioid has caused at least 46 confirmed deaths and has been proven to have a high potential for abuse with no approved medical use. Thirty-one of those deaths occurred in New York and 10 in North … Read More